This site uses cookies to improve your experience. By viewing our content, you are accepting the use of cookies. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country we will assume you are from the United States. View our privacy policy and terms of use.

Remove 2026 Remove Pharma Companies Remove Vaccine Related Topics
Cell Based Assays RNA Pharmaceuticals Clinical Development Marketing Virus Drugs Therapies Trials Treatment More Related Topics >
article thumbnail

Changes to UK Statutory Scheme go ahead despite pharma criticism

Drug Discovery World

DECEMBER 6, 2023

It intends to set amended payment percentages for 2024 to 2026 based on an allowed growth rate that has been increased to 2%. This means that companies will pay a rebate on the sales of branded medicines to the NHS of 21.9% in 2024, 24% in 2025 and 26.8% While the published rates are down on the record 27.5%

Government 147
Government Pharma Companies Science International 147
article thumbnail

The trends driving ELRIG Drug Discovery 2022

Drug Discovery World

OCTOBER 4, 2022

The global lab automation market for drug discovery is expected to grow by a CAGR of 5% between 2021 – 2026, according to a report by Mordor Intelligence. . As a project, it demonstrated the importance of collaboration between industry and academia to solve the remarkable challenge of developing a vaccine in record time. .

Drugs 130
Drugs Therapies Clinical Trials Cell Based Assays 130
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

 

Stay Connected

Join 42,000+ Insiders by signing up for our newsletter

About
About
Editions
Editions
Topics
Powered by Aggregage | Terms and Conditions | Your California Rights and Privacy Policy
© Aggregage 2024